HK1055745A1 - Cyclipostins, a method for their production and the use of the same. - Google Patents

Cyclipostins, a method for their production and the use of the same.

Info

Publication number
HK1055745A1
HK1055745A1 HK03108059A HK03108059A HK1055745A1 HK 1055745 A1 HK1055745 A1 HK 1055745A1 HK 03108059 A HK03108059 A HK 03108059A HK 03108059 A HK03108059 A HK 03108059A HK 1055745 A1 HK1055745 A1 HK 1055745A1
Authority
HK
Hong Kong
Prior art keywords
cyclipostins
physiologically compatible
production
compounds
same
Prior art date
Application number
HK03108059A
Other languages
English (en)
Inventor
Laszlo Vertesy
Klaus Ehrlich
Michael Kurz
Joachim Wink
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of HK1055745A1 publication Critical patent/HK1055745A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK03108059A 2000-05-04 2003-11-06 Cyclipostins, a method for their production and the use of the same. HK1055745A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10021731A DE10021731B4 (de) 2000-05-04 2000-05-04 Cyclipostine, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung derselben
PCT/EP2001/004652 WO2001083497A1 (de) 2000-05-04 2001-04-25 Cyclipostine, verfahren zu ihrer herstellung und verwendung derselben

Publications (1)

Publication Number Publication Date
HK1055745A1 true HK1055745A1 (en) 2004-01-21

Family

ID=7640768

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03108059A HK1055745A1 (en) 2000-05-04 2003-11-06 Cyclipostins, a method for their production and the use of the same.

Country Status (28)

Country Link
EP (1) EP1280812B1 (xx)
JP (1) JP5038572B2 (xx)
KR (1) KR100779867B1 (xx)
CN (1) CN1216890C (xx)
AR (1) AR028398A1 (xx)
AT (1) ATE288442T1 (xx)
AU (2) AU2001262229B2 (xx)
BR (1) BR0110459A (xx)
CA (1) CA2407808C (xx)
CZ (1) CZ20023547A3 (xx)
DE (2) DE10021731B4 (xx)
DK (1) DK1280812T3 (xx)
EE (1) EE05090B1 (xx)
ES (1) ES2236234T3 (xx)
HK (1) HK1055745A1 (xx)
HR (1) HRP20020864A2 (xx)
HU (1) HUP0300306A3 (xx)
IL (2) IL152612A0 (xx)
MX (1) MXPA02010297A (xx)
NO (1) NO330438B1 (xx)
NZ (1) NZ522352A (xx)
PL (1) PL358328A1 (xx)
PT (1) PT1280812E (xx)
RU (1) RU2266911C2 (xx)
SK (1) SK15602002A3 (xx)
WO (1) WO2001083497A1 (xx)
YU (1) YU81502A (xx)
ZA (1) ZA200208928B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8110665B2 (en) 2003-11-13 2012-02-07 Hanmi Holdings Co., Ltd. Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
DK2256134T3 (en) 2003-11-13 2014-02-24 Hanmi Science Co Ltd IgG Fc fragment to a drug carrier and process for preparation thereof
KR100754667B1 (ko) 2005-04-08 2007-09-03 한미약품 주식회사 비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물
EP1894601A1 (en) 2006-08-29 2008-03-05 sanofi-aventis Treating mycobacterial infections with cyclipostins
KR200453850Y1 (ko) * 2008-04-23 2011-05-30 주식회사 에이티티알앤디 수질 관리 센서 내장형 수도미터기
KR102073748B1 (ko) 2013-01-31 2020-02-05 한미약품 주식회사 재조합 효모 형질전환체 및 이를 이용하여 면역글로불린 단편을 생산하는 방법
AR096891A1 (es) 2013-07-12 2016-02-03 Hanmi Pharm Ind Co Ltd Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04145089A (ja) * 1990-10-05 1992-05-19 Nippon Kayaku Co Ltd 抗生物質ｎｋ９０１０９３、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤
JPH0656859A (ja) * 1991-07-25 1994-03-01 Nippon Kayaku Co Ltd 抗生物質ｎｋ９０１０９３ａ、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤

Also Published As

Publication number Publication date
NO20025209D0 (no) 2002-10-30
KR100779867B1 (ko) 2007-11-27
MXPA02010297A (es) 2003-04-25
ES2236234T3 (es) 2005-07-16
PT1280812E (pt) 2005-05-31
BR0110459A (pt) 2003-03-11
NO330438B1 (no) 2011-04-11
IL152612A (en) 2009-11-18
AU2001262229B2 (en) 2007-01-25
ATE288442T1 (de) 2005-02-15
SK15602002A3 (sk) 2003-04-01
CA2407808A1 (en) 2002-10-30
HUP0300306A2 (hu) 2003-06-28
EP1280812B1 (de) 2005-02-02
YU81502A (sh) 2006-05-25
DE10021731A1 (de) 2001-11-15
JP2003531914A (ja) 2003-10-28
ZA200208928B (en) 2003-10-07
AU6222901A (en) 2001-11-12
HRP20020864A2 (en) 2004-12-31
WO2001083497A1 (de) 2001-11-08
JP5038572B2 (ja) 2012-10-03
CA2407808C (en) 2013-06-25
EE200200599A (et) 2004-04-15
HUP0300306A3 (en) 2004-10-28
DE10021731B4 (de) 2005-12-08
CN1216890C (zh) 2005-08-31
AR028398A1 (es) 2003-05-07
DE50105249D1 (de) 2005-03-10
DK1280812T3 (da) 2005-05-30
CN1427845A (zh) 2003-07-02
PL358328A1 (en) 2004-08-09
RU2266911C2 (ru) 2005-12-27
CZ20023547A3 (cs) 2003-02-12
EE05090B1 (et) 2008-10-15
KR20030009464A (ko) 2003-01-29
IL152612A0 (en) 2003-06-24
NO20025209L (no) 2002-10-30
NZ522352A (en) 2004-06-25
EP1280812A1 (de) 2003-02-05

Similar Documents

Publication Publication Date Title
ATE316083T1 (de) Adamantanderivate
MY136430A (en) N-adamantylmethyl derivatives, pharmaceutical compositions containing them and processes for their preparation
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
MXPA05013752A (es) Procedimiento e intermediarios para la preparacion de (1r,2s,5s)-6,6-dimetil-3-azabiciclo[3,1,0]exan-2-carboxilatos o sales de los mismos.
NO20024772D0 (no) Percyquinnin, fremgangsmåte for dets fremstilling og dets anvendelse som et legemiddel
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
GB0123589D0 (en) Organic compounds
DE60112330D1 (en) Pyrazolopyridinderivate
GB0109122D0 (en) Novel compounds
DE69907419D1 (en) Antitumorwirkstoffe
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
MXPA02012889A (es) Esteres de acidos 4-alcoxi-ciclohexano-1-amino-carboxilicos y procedimiento para su obtencion.
MXPA04005484A (es) Procedimiento de preparacion de derivados de equinocandina.
HK1055745A1 (en) Cyclipostins, a method for their production and the use of the same.
SE0102057D0 (sv) New Salts I
WO2002100327A3 (en) Substituted 1-benzazepines and derivatives thereof
AU2002248531A1 (en) Pyrazolopyriadine derivatives
AU2002218422A1 (en) New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
AU2001244999A1 (en) Naphthamide neurokinin antagonists for use as medicaments
GEP20032928B (en) Halo Derivatives of 9-Deoxo-9a-Aza-9a-Homerythromycin A, Method for its Production, Pharmaceutical Compositions Containing the Same and Their Use for Treatment or Prevention of Bacterial Infections
MXPA03009723A (es) Procedimientos e intermediarios para preparar epoxidos substituidos de bencilo.
DE60335960D1 (de) 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA04001851A (es) Inda-1-onas c2-disustituidas y sus derivados, metodo para su produccion y su uso como medicamentos.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150425